Select for export EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION Details DOI 10.1016/j.jval.2026.03.635 Copy citation Copy BibTeX Value in Health 2026-05-31 Yosr Ziadi, Taehwan Park OpenAlex Published psilocybin DepressionPersonality ChangeTreatment-Resistant Depression Other Medicine More
Select for export Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls Details DOI 10.1016/j.nsa.2023.103646 Copy citation Copy BibTeX Neuroscience Applied 2022-12-31 Miriam L. Navarro, Alberte Wollesen Breum, Annette Johansen, Brice Ozenne, Vibe G. Frøkjær, Gitte M. Knudsen OpenAlex Published psilocybin DepressionAnxietyPersonality Change Other Escitalopram More
Select for export Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome Details DOI 10.1007/s00213-022-06286-3 PubMed 36469097 Copy citation Copy BibTeX Psychopharmacology 2022-12-04 Valeria Buzzelli, Emilia Carbone, Antonia Manduca, Sara Schiavi, Alessandro Feo, Julia V. Perederiy OpenAlex Published psilocybin Receptor PharmacologyPersonality ChangeAnimal Study Animal Study Fragile X syndrome More
Select for export [CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN]. Details PubMed 14144273 Copy citation Copy BibTeX Unknown journal 1964-02-29 REDA GC, VELLA G, CANCRINI L, D AGOSTINO E. Europe PMC Published psilocybin DepressionPharmacologyConsciousness Other Salivary Glands More